• Medientyp: E-Artikel
  • Titel: Angiotensin-(1–7) Modulates Renal Vascular Resistance Through Inhibition of p38 Mitogen-Activated Protein Kinase in Apolipoprotein E–Deficient Mice
  • Beteiligte: Potthoff, Sebastian A.; Fähling, Michael; Clasen, Tilman; Mende, Susanne; Ishak, Bassam; Suvorava, Tatsiana; Stamer, Stefanie; Thieme, Manuel; Sivritas, Sema H.; Kojda, Georg; Patzak, Andreas; Rump, Lars C.; Stegbauer, Johannes
  • Erschienen: Ovid Technologies (Wolters Kluwer Health), 2014
  • Erschienen in: Hypertension
  • Sprache: Englisch
  • DOI: 10.1161/hypertensionaha.113.02289
  • ISSN: 0194-911X; 1524-4563
  • Schlagwörter: Internal Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p> Apolipoprotein E–deficient (apoE(−/−)) mice fed on Western diet are characterized by increased vascular resistance and atherosclerosis. Previously, we have shown that chronic angiotensin (Ang)-(1–7) treatment ameliorates endothelial dysfunction in apoE(−/−) mice. However, the mechanism of Ang-(1–7) on vasoconstrictor response to Ang II is unknown. To examine Ang-(1–7) function, we used apoE(−/−) and wild-type mice fed on Western diet that were treated via osmotic minipumps either with Ang-(1–7) (82 μg/kg per hour) or saline for 6 weeks. We show that Ang II–induced renal pressor response was significantly increased in apoE(−/−) compared with wild-type mice. This apoE(−/−)-specific response is attributed to reactive oxygen species–mediated p38 mitogen–activated protein kinase activation and subsequent phosphorylation of myosin light chain (MLC <jats:sub>20</jats:sub> ), causing renal vasoconstriction. Here, we provide evidence that chronic Ang-(1–7) treatment attenuated the renal pressor response to Ang II in apoE(−/−) mice to wild-type levels. Ang-(1–7) treatment significantly decreased renal inducible nicotinamide adenine dinucleotide phosphate subunit p47phox levels and, thus, reactive oxygen species production that in turn causes decreased p38 mitogen-activated protein kinase activity. The latter has been confirmed by administration of a specific p38 mitogen-activated protein kinase inhibitor SB203580 (5 μmol/L), causing a reduced renal pressor response to Ang II in apoE(−/−) but not in apoE(−/−) mice treated with Ang-(1–7). Moreover, Ang-(1–7) treatment had no effect in Mas(−/−)/apoE(−/−) double-knockout mice confirming the specificity of Ang-(1–7) action through the Mas-receptor. In summary, Ang-(1–7) modulates vascular function via Mas-receptor activation that attenuates pressor response to Ang II in apoE(−/−) mice by reducing reactive oxygen species–mediated p38 mitogen-activated protein kinase activity. </jats:p>
  • Zugangsstatus: Freier Zugang